Eugia Pharma Specialities Ltd restarts production at terminally sterilized product lines

Eugia Pharma Specialities Limited has restarted production in its terminally sterilized product lines at its Unit-III, that was temporarily stopped to address some of the observations of USFDA in their recent inspection concluded on 2nd February 2024. We expect to start the production in the aseptic lines of the facility in the month of March 2024.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1027.45 as compared to the previous close of Rs. 1028.15. The total number of shares traded during the day was 24855 in over 1206 trades.

The stock hit an intraday high of Rs. 1032.35 and intraday low of 1015.55. The net turnover during the day was Rs. 25422891.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 EugiaPharmaSpecialities ProductionRestart TerminallySterilizedProductLines Unit3